Plea Due in MedImmune Stock Case
497832
A former executive at the Gaithersburg biotechnology firm MedImmune Inc. is scheduled to plead guilty today to criminal charges related to his allegedly improper stock trades, according to court papers.
455780
Defense and prosecution attorneys in theÂ Hewlett-Packard spying caseÂ are scheduled to meet with the presiding judge Dec. 4 to discuss possible plea bargains, the San Jose Mercury News reported Saturday.
360178
MedImmune Inc. said yesterday that it would pay a Massachusetts drug company up to $500 million for the rights to co-develop and sell new cancer treatments.
243951
A former executive of biotechnology firm MedImmune Inc. faces 15 to 21 months in prison after pleading guilty Friday to securities fraud and perjury in US District Court in Washington.
54609
SEC upgrades investigation into vaccine manufacturer.
456781
The Schering-Plough Corporation has agreed to pay $435 million and plead guilty to conspiracy to settle charges of marketing drugs for unapproved uses and overcharging Medicaid.
735798
An institutional investor in MedImmune has sent a third letter to the firm's board pushing for a sale of the company, saying that negative Wall Street reaction to recent quarterly earnings "must be viewed as a total rejection of the management's strategy."
460110
Biotechnology company InterMune Inc. on Tuesday said it received a subpoena from the US Department of Justice demanding information related to its key drug Actimmune, which is designed to spur the immune system.
698753
MedImmune Inc.&#39;s cancellation of trials for an arthritis and psoriasis treatment sent the company&#39;s stock lower Monday and helped drag down the entire biotechnology sector.
226791
A court ruling upholding the  patent on blockbuster blood-thinning drug Plavix has reignited  talk France&#39;s Sanofi-Aventis  will bid for its smaller  U.S. partner Bristol-Myers Squibb Co. .
709830
Encysive gets set for a showdown with the FDA.
526264
Infineon Technologies AG has agreed to plead guilty and to pay a $160 million fine for participating in an international conspiracy to fix prices in the DRAM market, the US Department of Justice (DOJ) said today.
680034
An executive of the company that makes the diabetes drug Avandia said a researcher who was among the first to link it to heart problems would be held liable for the $4 billion GlaxoSmithKline PLC lost in stock value as a result of his findings, Dr. John B. Buse testified before congressional investigators yesterday.
764344
The anti-industry crusader targets pharmaceuticals.
444847
A drug wholesaler accused of overcharging for flu vaccine agreed Wednesday to turn over its remaining inventory -- a total of five vials -- and to no longer buy or sell it.
26459
Drugmaker Sanofi-Aventis , the target of a lawsuit seeking class-action status filed on behalf of shareholders, on Friday vowed to fight allegations it hid the side-effects of its anti-obesity drug Acomplia.
89817
A U.S. law firm plans to file a lawsuit seeking class-action status against Sanofi-Aventis  on behalf of shareholders, alleging the pharmaceuticals group hid the side-effects of its anti-obesity drug Acomplia, French daily Les Echos reported.